Commercializing IPR in Synthetic Biology
Time & Location
About the Event
Alexander Bützow - Commercializing IPR in Synthetic Biology
14:00 - 14:10 Welcome and Synbio Powerhouse News - Tuula Palmén, Co-creation Manager in Synthetic biology, VTT
14:10 - 15:00 What are IPRs and why are they important?; SynBio IPR landscape; I have a SynBio invention, now what - Alexander Bützow, IP and Contract Lawyer, University of Helsinki
15:00-15:05 Common marketable projects - James Evans, Lab Manager at Biogarage, Aalto University
15:05 - 15:50 Q&A
15:50 - 16:00 Wrap-up
ABOUT THE PRESENTER:
Alexander Bützow is an IP and contract lawyer currently working as a legal counsel at the University of Helsinki’s Research Services. Alex’s job consists of assisting researchers in all legal matters pertaining to research and innovation, such as technology transfer (licensing and commercialization), RDI agreements and business collaboration. Alex has a strong background and special interest in matters relating to synthetic biology, especially with regard to SynBio IPR strategy and commercialization.
AT THIS EVENT YOU WILL LEARN ABOUT:
What are IPRs and why are they important?
- Right to prohibit
- Utility models
- Trade secrets
- Upstream vs. downstream innovation
SynBio IPR landscape
- Network effects
- Proprietary vs. open source
- Cross-licensing, patent pools and clearing houses
I have a SynBio invention, now what?
- Finnish employment and academic innovation laws
- Publication, patent or trade secret
- How to develop a technology asset
- Start-up, assignment or licensing
We look forward to seeing you on November 19!
You must register to receive the Zoom-link!